Cardiovascular adverse reactions associated with escitalopram in patients with underlying cardiovascular diseases: a systematic review and meta-analysis.

Front Psychiatry · 2023 · PMC10556499 · PMID 37810602

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

The RR was 1.03 (95% CI 0.84–1.26; 5 studies; 773 patients), indicating a slightly higher risk of discontinuation of study medication in the escitalopram group than in the placebo group, but this difference did not reach statistical significance as the 95% CI included the null value of 1.0.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.